COP11 Update: Deep Divide Over Regulation of E-cigarettes and Nicotine Pouches as EU Pushes Back Against "Total Ban" Draft

Nov.21.2025
COP11 Update: Deep Divide Over Regulation of E-cigarettes and Nicotine Pouches as EU Pushes Back Against "Total Ban" Draft
At the ongoing COP11 in Geneva,a bloc led by Brazil and the Maldives has submitted a draft proposing "prohibition" as the primary policy path. In response, the European Union has submitted amendments requesting that the wording be adjusted to optional regulation, preserving the right of member states to decide on sales bans based on their own national laws.

Key Point

 

  • Draft Direction: Brazil, Maldives, Panama, and Thailand are pushing a draft decision recommending the prohibition of the manufacture, import, sale, presentation, and use of products such as e-cigarettes and nicotine pouches.
  • Scope of Controversy: The proposed ban covers ENDS (electronic nicotine delivery systems), ENNDS (electronic non-nicotine delivery systems), and nicotine pouches, triggering widespread attention.
  • EU Position: The EU opposes a "one-size-fits-all" ban and has submitted amendments suggesting the language be changed from "prohibit" to regulatory options that "could include prohibition."
  • Legal Limitations: The EU emphasizes the addition of the clause "as appropriate under national laws" to ensure member states retain regulatory flexibility.
  • Core Conflict: The central dispute of this COP11 is whether to push for a global ban at the FCTC level or to grant countries the power to determine their own regulatory models.

 

2Firsts, November 21, 2025 — According to Pouch Patrol, at the 11th Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control, Parties are currently engaged in intensive consultations regarding the text of the draft decision under Agenda Item 4.5 concerning novel and emerging nicotine products (including e-cigarettes and nicotine pouches).

 

The current controversy centers on whether the Convention should explicitly call for a "ban" on such products or retain the right of member states to "regulate" them in accordance with domestic law.

 

Draft Proposal: Prohibition as the Primary Measure

 

According to the draft decision (Document FCTC/COP11/P/CONF./5(a)) jointly submitted by Brazil, Maldives, Panama, and Thailand, the proponents urge Parties to implement stricter control measures.

 

Paragraph 2(a)(i) of the original draft suggests measures to "prohibit or restrict the manufacture, importation, distribution, presentation, sale and use of all novel and emerging nicotine products." The draft specifically names electronic nicotine delivery systems (ENDS), electronic non-nicotine delivery systems (ENNDS), and nicotine pouches.

 

Furthermore, the draft emphasizes a firm rejection of the tobacco industry's "harm reduction" narrative, viewing it primarily as a strategy to avoid regulation.

 

EU Amendment: Emphasizing National Laws and Regulatory Flexibility

 

In response to the aforementioned draft, the European Union delegation has submitted a formal Union Position proposing key changes to the resolution's wording.

 

According to the amendment text submitted by the EU, the bloc proposes changing "prohibiting or restricting" to "taking comprehensive regulatory measures, which could include prohibiting or restricting." The EU also requests the addition of the qualifying phrase "as appropriate under national laws" in relevant clauses.

 

In its position paper, the EU notes its support for effective measures to prevent nicotine addiction but emphasizes that the implementation of such measures should align with the regulatory frameworks of individual nations.

 

Analysis of Policy Divergence

 

The core difference between the two documents lies in the definition of the legal binding force of "prohibition":

 

  • The Original Draft prioritizes "prohibition" as the recommended policy option, with a scope covering products like nicotine pouches that are already legal in some markets.
  • The EU Amendment seeks to preserve policy space for member states. By adding terms such as "comprehensive regulatory measures" and "under national laws," the EU advocates for fulfilling Convention obligations through strict market regulation (e.g., age limits, ingredient regulations) without necessarily implementing a total ban.

 

Image source: Pouch Patrol

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives